Arcutis Biotherapeutics News

Analysts' Revenue Estimates For Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Are Surging Higher

Shareholders in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The consensus estimated reven

Simply Wall StApr 26 06:18 ET

Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)

TipRanksApr 22 02:50 ET

Express News | Needham Reiterates Buy on Arcutis Biotherapeutics, Maintains $16 Price Target

Moomoo 24/7Apr 12 06:44 ET

Arcutis Biotherapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/12/2024 34.57% Needham → $16 Reiterates Buy → Buy 02/28/2024 -7.49% Goldman Sachs $6 → $11 Maintains Ne

BenzingaApr 12 06:43 ET

Analysts Are Bullish on These Healthcare Stocks: GoodRx Holdings (GDRX), Arcutis Biotherapeutics (ARQT)

TipRanksApr 12 06:40 ET

Arcutis Biotherapeutics Welcomes New CFO David Topper

TipRanksApr 10 16:33 ET

Arcutis Biotherapeutics Appoints CFO

Seeking AlphaApr 10 08:16 ET

Express News | Arcutis Appoints David Topper As Chief Financial Officer

Moomoo 24/7Apr 10 08:05 ET

Arcutis Biotherapeutics: Smither Will Remain to End of April to Ensure Smooth Transition >ARQT

Arcutis Biotherapeutics: Smither Will Remain to End of April to Ensure Smooth Transition >ARQT

Dow JonesApr 10 08:02 ET

Arcutis Biotherapeutics: Topper Replaces Interim CFO John Smither >ARQT

Arcutis Biotherapeutics: Topper Replaces Interim CFO John Smither >ARQT

Dow JonesApr 10 08:01 ET

Press Release: Arcutis Appoints David Topper as Chief Financial Officer

Arcutis Appoints David Topper as Chief Financial Officer Industry veteran with over 40 years of experience in finance, investment management, and investment banking WESTLAKE VILLAGE, Calif., April 1

Dow JonesApr 10 08:00 ET

Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Arcutis Biotherapeutics (ARQT)

TipRanksApr 10 02:30 ET

Buy Rating on Arcutis Biotherapeutics Bolstered by Projected Q1 Sales Beat and 2024 Upside Potential

TipRanksApr 10 02:21 ET

Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference

WESTLAKE VILLAGE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology,

GlobeNewswireMar 28 08:00 ET

Analysts Offer Insights on Healthcare Companies: Marinus (MRNS), Arcutis Biotherapeutics (ARQT) and Axsome Therapeutics (AXSM)

TipRanksMar 27 03:20 ET

Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?

Yahoo FinanceMar 19 09:40 ET

Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Fulcrum Therapeutics (FULC) and AC Immune SA (ACIU)

TipRanksMar 19 01:50 ET

Wall Street Analysts See a 54.78% Upside in Arcutis Biotherapeutics, Inc. (ARQT): Can the Stock Really Move This High?

Yahoo FinanceMar 18 09:55 ET

Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Adaptimmune Therapeutics (ADAP) and Arcutis Biotherapeutics (ARQT)

TipRanksMar 13 02:30 ET

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

BenzingaMar 11 10:37 ET